163 related articles for article (PubMed ID: 9723444)
1. FTY720: a new immunosuppressive agent with novel mechanism(s) of action.
Kahan BD
Transplant Proc; 1998 Aug; 30(5):2210-3. PubMed ID: 9723444
[No Abstract] [Full Text] [Related]
2. Preclinical evaluation of a new immunosuppressive agent, FTY720.
Troncoso P; Kahan BD
Clin Biochem; 1998 Jul; 31(5):369-73. PubMed ID: 9721436
[TBL] [Abstract][Full Text] [Related]
3. FTY720: mechanisms of action and its effect on organ transplantation (review).
Suzuki S
Transplant Proc; 1999 Nov; 31(7):2779-82. PubMed ID: 10578288
[No Abstract] [Full Text] [Related]
4. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
[No Abstract] [Full Text] [Related]
5. FTY 720.
Drugs R D; 1999 Jan; 1(1):78-80. PubMed ID: 10565994
[No Abstract] [Full Text] [Related]
6. Prolongation of concordant xenograft survival by treatment with FTY720.
Miyata Y; Ohdan H; Noriyuki T; Shintaku S; Shibata S; Yamamoto H; Fan XH; Fudaba Y; Yoshioka S; Asahara T; Fukuda Y; Dohi K
Transplant Proc; 1998 Dec; 30(8):4163-5. PubMed ID: 9865334
[No Abstract] [Full Text] [Related]
7. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
[No Abstract] [Full Text] [Related]
8. A short-course therapy with FTY720 prolongs allograft survival after canine kidney transplantation.
Omura T; Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Kishida A; Matsushita M; Furukawa H; Todo S
Transplant Proc; 1999 Nov; 31(7):2783-4. PubMed ID: 10578289
[No Abstract] [Full Text] [Related]
9. Donor pretreatment with FTY720 increases graft lymphocytes but does not affect graft survival following rat small bowel transplantation.
Sakagawa T; Kiyochi H; Honda K; Kobayashi N
Transplant Proc; 2002 May; 34(3):973-4. PubMed ID: 12034266
[No Abstract] [Full Text] [Related]
10. Dose-dependent study of a novel immunosuppressant, FTY720, with the canine renal allograft transplantation model.
Suzuki T; Shimamura T; Jin MB; Yokota R; Fukai M; Iida J; Taniguchi M; Magata S; Horiuchi H; Yamashita K; Nomura M; Omura T; Kishida A; Furukawa H; Todo S
Transplant Proc; 1999; 31(1-2):1208-9. PubMed ID: 10083540
[No Abstract] [Full Text] [Related]
11. FTY720 inhibits the mRNA expression of intragraft cytotoxic molecules, leading to cardiac allograft survival.
Nakajima H; Sun E; Mizuta N; Fujiwara I; Oka T
Transplant Proc; 1998 Aug; 30(5):2217-20. PubMed ID: 9723446
[No Abstract] [Full Text] [Related]
12. FTY720: A new kid on the block for transplant immunosuppression.
Aki FT; Kahan BD
Expert Opin Biol Ther; 2003 Jul; 3(4):665-81. PubMed ID: 12831371
[TBL] [Abstract][Full Text] [Related]
13. An effect of FTY720 on acute rejection in canine renal transplantation.
Yuzawa K; Otsuka M; Taniguchi H; Takada Y; Sakurayama N; Jinzenji Y; Suzuki S; Fukao K
Transplant Proc; 1998 Jun; 30(4):1046. PubMed ID: 9636422
[No Abstract] [Full Text] [Related]
14. Immunosuppressive effect of a new drug, FTY720, on lymphocyte responses in vitro and cardiac allograft survival in rats.
Suzuki S; Enosawa S; Kakefuda T; Li XK; Mitsusada M; Takahara S; Amemiya H
Transpl Immunol; 1996 Sep; 4(3):252-5. PubMed ID: 8893458
[No Abstract] [Full Text] [Related]
15. Pretreatment with FTY720 alone induced long-term survival of mouse heart allograft.
Zhang L; Zhu T; Sun EW; Shen SQ; Min ZL; Chen ZK
Transplant Proc; 2003 Feb; 35(1):567-8. PubMed ID: 12591534
[No Abstract] [Full Text] [Related]
16. Effect of a novel immunosuppressant, FTY720, on heart and liver transplantations in rats.
Yamashita K; Nomura M; Omura T; Takehara M; Suzuki T; Shimamura T; Kishida A; Furukawa H; Murakami M; Uede T; Todo S
Transplant Proc; 1999; 31(1-2):1178-9. PubMed ID: 10083526
[No Abstract] [Full Text] [Related]
17. FTY720, a novel immunosuppressant, shows a synergistic effect in combination with FK 506 in rat allograft models.
Hoshino Y; Yanagawa Y; Ohtsuki M; Nakayama S; Hashimoto T; Chiba K
Transplant Proc; 1999; 31(1-2):1224-6. PubMed ID: 10083547
[No Abstract] [Full Text] [Related]
18. FTY720 compares with FK 506 as rescue therapy in rat heterotopic cardiac transplantation.
Xu M; Pirenne J; Antoniou S; Gunson B; D'Silva M; McMaster P
Transplant Proc; 1998 Aug; 30(5):2221-2. PubMed ID: 9723447
[No Abstract] [Full Text] [Related]
19. FTY720 alters lymphocyte homing and protects allografts without inducing general immunosuppression.
Brinkmann V; Chen S; Feng L; Pinschewer D; Nikolova Z; Hof R
Transplant Proc; 2001; 33(1-2):530-1. PubMed ID: 11266942
[No Abstract] [Full Text] [Related]
20. Update on pharmacokinetic/pharmacodynamic studies with FTY720 and sirolimus.
Kahan BD
Ther Drug Monit; 2002 Feb; 24(1):47-52. PubMed ID: 11805722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
